The effect of Glucagon-Like Peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patients

Publikation: Bidrag til tidsskriftTidsskriftartikelfagfællebedømt

Exogenous Glucagon-Like Peptide-2 (GLP-2) treatment improves intestinal wet weight absorption in short bowel syndrome (SBS) patients. In healthy subjects, administration of GLP-2 increases small intestinal blood flow. The aim of the study was to evaluate the effect of GLP-2 on mesenteric blood flow and dynamic changes in cardiac parameters in SBS patients with jejunostomy and varying length of remnant small intestine.
OriginalsprogEngelsk
TidsskriftRegulatory Peptides
Vol/bind168
Udgave nummer1-3
Sider (fra-til)32-8
Antal sider7
ISSN0167-0115
DOI
StatusUdgivet - 2011

ID: 34043197